当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 现金流量表

罗欣药业

(002793)

  

流通市值:53.97亿  总市值:54.05亿
流通股本:10.86亿   总股本:10.88亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金697,946,433.632,344,354,122.441,842,186,793.321,245,971,833.27
  收到的税费返还303,555.853,468,303.62,873,231.11,985,419.74
  收到其他与经营活动有关的现金29,303,548.9233,556,341.24179,164,142.91118,743,992.89
  经营活动现金流入小计727,553,538.42,381,378,767.282,024,224,167.331,366,701,245.9
  购买商品、接受劳务支付的现金126,321,656.94352,584,603.59420,337,957.89261,481,916
  支付给职工以及为职工支付的现金145,481,515.27577,898,716.49434,482,522.59315,039,515.42
  支付的各项税费60,274,078.74189,702,765.4132,467,559.3989,565,565.43
  支付其他与经营活动有关的现金253,768,308.321,008,127,003.53756,820,332.74482,721,870.57
  经营活动现金流出小计585,845,559.272,128,313,089.011,744,108,372.611,148,808,867.42
  经营活动产生的现金流量净额141,707,979.13253,065,678.27280,115,794.72217,892,378.48
二、投资活动产生的现金流量:
  收回投资收到的现金-13,504,732.97--
  取得投资收益收到的现金-54,665.2428,529,590.17-
  处置固定资产、无形资产和其他长期资产收回的现金净额51,0003,801,649.09639,068.35511,346.35
  处置子公司及其他营业单位收到的现金净额35,884,737.5104,174,083.3443,981,454.068,350,651.16
  收到的其他与投资活动有关的现金2,450,00054,270,100.261,350,000450,000
  投资活动现金流入小计38,385,737.5175,805,230.974,500,112.589,311,997.51
  购建固定资产、无形资产和其他长期资产支付的现金4,626,370.3432,183,595.1219,598,628.612,254,247.62
  投资支付的现金4,000,00012,000,0008,000,0004,000,000
  支付其他与投资活动有关的现金-7,562,921.433,889,062.713,889,062.71
  投资活动现金流出小计8,626,370.3451,746,516.5531,487,691.3120,143,310.33
  投资活动产生的现金流量净额29,759,367.16124,058,714.3543,012,421.27-10,831,312.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金15,170,6203,637,3503,637,3503,637,350
  其中:子公司吸收少数股东投资收到的现金15,170,6203,637,3503,637,3503,637,350
  取得借款收到的现金189,000,000948,490,000845,500,000323,500,000
  收到其他与筹资活动有关的现金120,000,000354,165,719.3360,004,242.96241,504,242.96
  筹资活动现金流入小计324,170,6201,306,293,069.31,209,141,592.96568,641,592.96
  偿还债务支付的现金135,000,0001,209,136,484.991,128,668,242.51579,373,287.5
  分配股利、利润或偿付利息支付的现金12,974,871.0848,984,069.4338,228,040.2423,963,348.75
  支付其他与筹资活动有关的现金146,413,085.26383,191,921.33335,234,801.44265,541,493.73
  筹资活动现金流出小计294,387,956.341,641,312,475.751,502,131,084.19868,878,129.98
  筹资活动产生的现金流量净额29,782,663.66-335,019,406.45-292,989,491.23-300,236,537.02
四、汇率变动对现金及现金等价物的影响-1,523,243.08-1,229,131.41-1,832,533.11-1,277,356.58
五、现金及现金等价物净增加额199,726,766.8740,875,854.7628,306,191.65-94,452,827.94
  加:期初现金及现金等价物余额329,247,870.08289,389,415.42289,389,415.42289,389,415.42
  期末现金及现金等价物余额528,974,636.95330,265,270.18317,695,607.07194,936,587.48
补充资料:
  净利润--284,526,170.23-21,996,782
  资产减值准备-55,335,018.07--43,055,461.79
  固定资产和投资性房地产折旧-149,555,483.91-76,716,221.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-149,555,483.91-76,716,221.45
  无形资产摊销-48,030,377.32-23,140,233.99
  长期待摊费用摊销-10,220,205.53-8,492,308.2
  处置固定资产、无形资产和其他长期资产的损失--3,084,463.82--4,276,148.66
  固定资产报废损失-1,817,807.96-1,722.53
  公允价值变动损失-35,351,860.47--
  财务费用-56,080,162.34-31,473,184.05
  投资损失-13,320,728.13--857,350.34
  递延所得税--6,192,158.24-15,261,871.78
  其中:递延所得税资产减少-1,165,372.98-18,595,087.97
    递延所得税负债增加--7,357,531.22--3,333,216.19
  存货的减少-81,290,606.94-46,437,682.22
  经营性应收项目的减少-33,475,639.84-224,462,178.82
  经营性应付项目的增加-27,559,615.38--200,269,102.54
  其他-26,307,819.19-13,318,722.52
  现金的期末余额-330,265,270.18-194,936,587.48
  减:现金的期初余额-289,389,415.42-289,389,415.42
  现金及现金等价物的净增加额-40,875,854.76--94,452,827.94
公告日期2026-04-232026-04-232025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑